World Mineralys Advances Lorundrostat Toward FDA Approval for Hypertension Mineralys Therapeutics, Inc. (Nasdaq: MLYS) is progressing towards filing a new drug application (NDA) for its leading drug candidate, lorundrostat, following a series of... Editorial16 August, 2025
Health Alarming Decline in U.S. Children’s Health: New Study Reveals Stark Realities The health of U.S. children has seen a significant decline over the past 17 years, with contemporary youth facing higher rates of obesity, chronic... Editorial8 July, 2025